Dicycloverine Hydrochloride
Hepatic or renal disease, urinary retention, paralytic ileus, hyperthyroidism, hypertension, congestive heart failure, cardiac tachyarrhythmia, children, elderly, pregnancy.
Gastrointestinal tract spasm, Intestinal hypermotility, Irritable bowel syndrome (IBS)
Intestinal obstruction; intestinal atony; myasthenia gravis; glaucoma; reflux oesophagitis; infants <6 mth; lactation.
N/A
Difficulty in accommodation, exacerbation of glaucoma; tachycardia, palpitations, arrhythmias; urinary retention; restlessness; confusion, excitement, hallucination and delirium. Potentially Fatal: Respiratory arrest in infants <10 wk.
Dicycloverine HCl relieves smooth muscle spasm in the GI and urinary tract. This effect is partly due to antimuscarinic action and partly direct action on the smooth muscle.
Antagonise the effect of drugs that affect GI motility e.g. metoclopramide. Absorption affected by concurrent admin with antacids.
N/A
Oral Tablet/Syrup Gastrointestinal tract spasm Adult: 10-20 mg tid. Intramuscular Gastrointestinal tract spasm Adult: 20 mg 4 times a day given only for 1-2 days. Replace with oral therapy as soon as possible.
Oral Tablet/Syrup Gastrointestinal tract spasm Child: 2-12 yr: 10 mg tid; 6 mth-2 yr: 5-10 mg 3-4 times daily.
N/A
May be taken with or without food. May be taken before or after meals.
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.